Alkermes Plc Stock Investor Sentiment

ALKS Stock  USD 24.65  0.39  1.61%   
Slightly above 60% of all Alkermes Plc's private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Alkermes Plc suggests that some traders are interested. Alkermes Plc's investor sentiment overview provides quick insight into current market opportunities from investing in Alkermes Plc. The current market sentiment, together with Alkermes Plc's historical and current headlines, can help investors time the market. In addition, many technical investors use Alkermes Plc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Panic Vs Confidence

60

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Alkermes Plc's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Alkermes Plc.
Alkermes Plc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Alkermes daily returns and investor perception about the current price of Alkermes Plc as well as its diversification or hedging effects on your existing portfolios.

Alkermes Historical Sentiment

Although Alkermes Plc's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Alkermes, such as negative comments on social media and news outlets, may cause fear in the market and push Alkermes Plc's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Alkermes.
  

Alkermes Plc Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Alkermes Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Alkermes Plc Historical Investor Sentiment

Investor biases related to Alkermes Plc's public news can be used to forecast risks associated with an investment in Alkermes. The trend in average sentiment can be used to explain how an investor holding Alkermes can time the market purely based on public headlines and social activities around Alkermes Plc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Alkermes Plc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Alkermes Plc and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Alkermes Plc news discussions. The higher the estimate score, the more favorable the investor's outlook on Alkermes Plc.

Alkermes Plc Maximum Pain Price across 2024-05-17 Option Contracts

Alkermes Plc's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Alkermes Plc close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Alkermes Plc's options.
a day ago at zacks.com         
Deciphera Pharmaceuticals, Inc. Expected to Beat Earnings Estimates Can the Stock Move Higher?
zacks News
3 days ago at finance.yahoo.com         
Will Alkermes Proprietary Drugs Aid Amid Competition?
Yahoo News
six days ago at businesswire.com         
Nemvaleukin Alfa Drug Landscape Report 2024 An Interleukin-2 Receptor Agonist for the Treatment of S...
businesswire News
six days ago at gurufocus.com         
Why Lantheus Holdings Incs Stock Skyrocketed 11 percent in a Quarter
Gurufocus Stories at Macroaxis
over a week ago at zacks.com         
Alkermes Earnings Expected to Grow What to Know Ahead of Q1 Release
zacks News
over a week ago at finance.yahoo.com         
Alkermes to Report First Quarter Financial Results on May 1, 2024
Yahoo News
over a week ago at finance.yahoo.com         
Alkermes Earnings Expected to Grow What to Know Ahead of Q1 Release
Yahoo News
over a week ago at gurufocus.com         
Whats Driving Intra-Cellular Therapies Incs Surprising 20 percent Stock Rally?
Gurufocus Stories at Macroaxis
over a week ago at zacks.com         
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
zacks News
over a week ago at news.google.com         
Arizona State Retirement System Buys 1663 Shares of Alkermes plc - Defense World
Google News at Macroaxis
over a week ago at news.google.com         
Nisa Investment Advisors LLC Sells 2600 Shares of Alkermes plc - Defense World
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Acquisition by Lurker Nancy of 2323 shares of Alkermes Plc subject to Rule 16b-3
Yahoo News
over two weeks ago at businesswire.com         
Ovarian Cancer Opportunity Assessment and Forecast Report 2024 Sales of ImmunoGens Elahere Represent...
businesswire News
over two weeks ago at zacks.com         
Why Alkermes is a Top Growth Stock for the Long-Term
zacks News
over two weeks ago at investing.com         
Jefferies raises Alkermes stock target on positive OX2 data
Investing News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Alkermes Plc that are available to investors today. That information is available publicly through Alkermes media outlets and privately through word of mouth or via Alkermes internal channels. However, regardless of the origin, that massive amount of Alkermes data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Alkermes Plc news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Alkermes Plc relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Alkermes Plc's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Alkermes Plc alpha.

Alkermes Plc Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Disposition of 1308 shares by Michael Landine of Alkermes Plc at 32.18 subject to Rule 16b-3
02/16/2024
2
UBS cuts Alkermes rating to sell amid concerns over pipeline spread
02/20/2024
3
Acquisition by Richard Pops of 274328 shares of Alkermes Plc at 30.04 subject to Rule 16b-3
02/26/2024
4
Disposition of 2559 shares by Samuel Parisi of Alkermes Plc at 29.65 subject to Rule 16b-3
02/27/2024
5
Nomura Holdings Inc. Takes Position in Alkermes plc
03/01/2024
6
Insider Sell SVP, Chief Commercial Officer Christian Nichols Sells Shares of Alkermes PLC
03/18/2024
7
Redwood Investments LLC Has 3.22 Million Stock Position in Alkermes plc - MarketBeat
04/01/2024
8
ALKERMES PLC DL-,01 Revenue Breakdown MUN8AK TradingView - TradingView
04/03/2024
9
Does Alkermes Have A Healthy Balance Sheet
04/08/2024
10
Alkermes stock gains on sleeping disorder drug
04/09/2024
11
Why Alkermes is a Top Growth Stock for the Long-Term
04/10/2024
12
Arizona State Retirement System Buys 1663 Shares of Alkermes plc - Defense World
04/15/2024
13
Alkermes to Report First Quarter Financial Results on May 1, 2024
04/17/2024
14
Why Lantheus Holdings Incs Stock Skyrocketed 11 percent in a Quarter
04/18/2024
15
Deciphera Pharmaceuticals, Inc. Expected to Beat Earnings Estimates Can the Stock Move Higher
04/24/2024
When determining whether Alkermes Plc is a strong investment it is important to analyze Alkermes Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alkermes Plc's future performance. For an informed investment choice regarding Alkermes Stock, refer to the following important reports:

Complementary Tools for Alkermes Stock analysis

When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Global Correlations
Find global opportunities by holding instruments from different markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Alkermes Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alkermes Plc. If investors know Alkermes will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alkermes Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
3.06
Revenue Per Share
10.007
Quarterly Revenue Growth
0.239
Return On Assets
0.1281
Return On Equity
0.4622
The market value of Alkermes Plc is measured differently than its book value, which is the value of Alkermes that is recorded on the company's balance sheet. Investors also form their own opinion of Alkermes Plc's value that differs from its market value or its book value, called intrinsic value, which is Alkermes Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alkermes Plc's market value can be influenced by many factors that don't directly affect Alkermes Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alkermes Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alkermes Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alkermes Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.